Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: J Viral Hepat. 2023 Jun 6;30(8):700–709. doi: 10.1111/jvh.13857

Table 2.

Unadjusted and adjusted* modeled means (95% CI) of HBV serum markers in HBV-HIV co-infected versus HBV mono-infected North American adults, stratified by HBeAg status.

HBeAg(+) HBeAg(−)

N HBV-HIV HBV only Difference** P N HBV-HIV HBV only Difference** P


mean (95% CI) mean (95% CI)
HBeAg (log10 IU/mL) 112 NA NA

 Unadjusted 1.00
(0.74-1.27)
0.89
(0.60-1.18)
0.12
(−0.27-0.51)
0.55

 Adjusted 1.05
(0.45-1.66)
0.51
(−0.19-1.22)
0.54
(−0.01-1.08)
0.051 NA
HBsAg (log10 IU/mL) 101 88

 Unadjusted 3.49
(3.27-3.70)
3.27
(2.93-3.61)
0.21
(−0.18-0.61)
0.28 2.41
(2.03-2.79)
2.78
(2.46-3.09)
−0.37
(−0.85-0.12)
0.13

 Adjusted 3.85
(3.35-4.35)
3.17
(2.48-3.86)
0.68
(0.05-1.31)
0.03 2.00
(1.18-2.82)
3.04
(2.13-3.94)
−1.04
(−1.69- −0.38)
0.002
HBcrAg (log10 U/mL) 116 94

 Unadjusted 6.67
(6.23-7.11)
6.25
(5.88-6.62)
0.42
(−0.15-0.99)
0.15 3.36
(2.86-3.86)
2.80
(2.39-3.21)
0.56
(−0.08-1.19)
0.09

 Adjusted 6.59
(5.42-7.75)
5.51
(4.24-6.79)
1.08
(0.25-1.90)
0.01 4.14
(3.14-5.15)
3.64
(2.45-4.83)
0.50
(−0.40-1.40)
0.27
HBV RNA (log10 U/mL) 116 94

 Unadjusted 4.99
(4.62-5.36)
4.33
(3.85-4.81)
0.67
(0.07-1.27)
0.03 1.63
(1.21-2.06)
2.11
(1.75-2.47)
−0.48
(−1.02-0.07)
0.09

 Adjusted 5.60
(4.72-6.48)
3.70
(2.66-4.73)
1.90
(1.10-2.71)
<.001 1.87
(0.95-2.78)
2.66
(1.60-3.72)
−0.80
(−1.59- −0.01)
0.048

Acronyms: HBcrAg, Hepatitis B core-related antigen; HBeAg, Hepatitis B e antigen; HBsAg, Hepatitis B surface antigen; HBV, Hepatitis B virus; HIV, Human immunodeficiency virus; HBeAg, Hepatitis B e-antigen; NH, Non-Hispanic; RNA, Ribonucleic acid.

*

For age, sex (HBeAg+ models only), race (NH White, NH Black, NH Asian and other/missing), ALT category (≤1, >1-2, >2) and HBV DNA category (<20, 20-<1000, ≥1000-10000).

**

Mean (95%CI) difference in HBV-HIV co-infected versus HBV mono-infected participants.